Pka And Akip1 Interact To Mediate Camp-Driven Cox-2 Expression: A Potentially Pivotal Interaction In Preterm And Term Labour

Previously, we showed that cAMP increased COX-2 expression in myometrial cells via MAPK. Here, we have extended these observations, using primary myometrial cell cultures to show that the cAMP agonist, forskolin, enhances IL-1 beta-driven COX-2 expression. We then explored the role of A-kinase interacting protein (AKIP1), which modulates the effect of PKA on p65 activation. AKIP1 knockdown reversed the effect of forskolin, such that its addition inhibited IL-1 beta-induced COX-2 mRNA expression and reduced the IL-1 beta-induced increase in nuclear levels of p65 and c-jun. Forskolin alone and with IL-1 beta increased I kappa B alpha mRNA expression suggesting that in the context of inflammation and in the presence of AKIP1, cAMP enhances p65 activation. AKIP1 knockdown reversed these changes. Interestingly, AKIP1 knockdown had minimal effect on the ability of forskolin to repress either basal OTR expression or IL-1 beta-stimulated OTR mRNA expression. AKIP1 was up-regulated by IL-1 beta, but not stretch and was repressed by cAMP. The mRNA expression of AKIP1 increased in early labour in tandem with an increase in COX-2 mRNA and protein. AKIP1 protein levels were also increased with inflammation and stretch-induced preterm labour. Our results identify a second important cAMP effector-switch occurring at term in human myometrium and suggest that a hitherto unrecognized interaction may exist between AKIP1, NF kappa B and AP-1. These data add to the proposition that cAMP acts as a key regulator of human myometrial contractility.